PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14578467-4	2003	Using doxorubicin treatment in the HCT116 colon cancer cell line, we have shown that MIC-1 secretion into culture media is correlated with p53 pathway activation as measured by the up-regulation of its downstream transcriptional target p21.	Doxorubicin	6-17	growth differentiation factor 15	Homo sapiens	85-90	
14578467-4	2003	Using doxorubicin treatment in the HCT116 colon cancer cell line, we have shown that MIC-1 secretion into culture media is correlated with p53 pathway activation as measured by the up-regulation of its downstream transcriptional target p21.	Doxorubicin	6-17	tumor protein p53	Homo sapiens	139-142	
14578467-6	2003	Treatment of these animals with a single dose of doxorubicin led to activation of the p53 pathway and a nearly 4-fold elevation of the plasma MIC-1 level, which was paralleled by p21 induction in the tumor xenografts.	Doxorubicin	49-60	tumor protein p53	Homo sapiens	86-89	
14578467-6	2003	Treatment of these animals with a single dose of doxorubicin led to activation of the p53 pathway and a nearly 4-fold elevation of the plasma MIC-1 level, which was paralleled by p21 induction in the tumor xenografts.	Doxorubicin	49-60	growth differentiation factor 15	Homo sapiens	142-147	
14578467-6	2003	Treatment of these animals with a single dose of doxorubicin led to activation of the p53 pathway and a nearly 4-fold elevation of the plasma MIC-1 level, which was paralleled by p21 induction in the tumor xenografts.	Doxorubicin	49-60	H3 histone pseudogene 16	Homo sapiens	179-182